OXYPRONAL LP 40 mg/20 mg, comprimé sécable à libération prolongée — plaquette(s) aluminium PVC polyéthylène PVDC avec fermeture de sécurité enfant de 28 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930241639 -
CIP7
3024163 -
CIS
67007913
What the source publishes
- Holder
- G.L. PHARMA (AUTRICHE)
- Active ingredients
- CHLORHYDRATE D'OXYCODONE, OXYCODONE, NALOXONE, CHLORHYDRATE DE NALOXONE DIHYDRATÉ
- Form
- comprimé sécable à libération prolongée
- Package
- plaquette(s) aluminium PVC polyéthylène PVDC avec fermeture de sécurité enfant de 28 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- prescription limitée à 4 semaines ; prescription en toutes lettres sur ordonnance sécurisée ; stupéfiants
- Marketing status
- Déclaration d'arrêt de commercialisation
- Authorised on
- 2021-11-17
- Prescription
- Prescription or restricted
Names this record is found by
- OXYPRONAL LP 40 mg/20 mg, comprimé sécable à libération prolongée — plaquette(s) aluminium PVC polyéthylène PVDC avec fermeture de sécurité enfant de 28 comprimé(s)
- OXYPRONAL LP 40 mg/20 mg, comprimé sécable à libération prolongée
- CHLORHYDRATE D'OXYCODONE
- OXYCODONE
- NALOXONE
- CHLORHYDRATE DE NALOXONE DIHYDRATÉ
Complete source data
{
"cis": "67007913",
"cip7": "3024163",
"form": "comprimé sécable à libération prolongée",
"name": "OXYPRONAL LP 40 mg/20 mg, comprimé sécable à libération prolongée — plaquette(s) aluminium PVC polyéthylène PVDC avec fermeture de sécurité enfant de 28 comprimé(s)",
"cip13": "3400930241639",
"holder": "G.L. PHARMA (AUTRICHE)",
"routes": [
"orale"
],
"holders": [
"G.L. PHARMA (AUTRICHE)"
],
"currency": "EUR",
"marketed": false,
"bdmStatus": "Warning disponibilité",
"useDomain": "unknown",
"publicPrice": "19.42",
"authorisedOn": "2021-11-17",
"compositions": [
{
"name": "CHLORHYDRATE D'OXYCODONE",
"nature": "SA",
"strength": "40 mg",
"linkageNumber": "1",
"substanceCode": "05087",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "OXYCODONE",
"nature": "FT",
"strength": "36 mg",
"linkageNumber": "1",
"substanceCode": "46704",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "NALOXONE",
"nature": "FT",
"strength": "18 mg",
"linkageNumber": "2",
"substanceCode": "65807",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "CHLORHYDRATE DE NALOXONE DIHYDRATÉ",
"nature": "SA",
"strength": "21,8 mg",
"linkageNumber": "2",
"substanceCode": "79853",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription limitée à 4 semaines ; prescription en toutes lettres sur ordonnance sécurisée ; stupéfiants",
"dispensingFee": "1.02",
"medicinePrice": "18.40",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "OXYPRONAL LP 40 mg/20 mg, comprimé sécable à libération prolongée",
"marketingStatus": "Déclaration d'arrêt de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "plaquette(s) aluminium PVC polyéthylène PVDC avec fermeture de sécurité enfant de 28 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"15 %"
],
"marketingDeclaredOn": "2023-11-20",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE D'OXYCODONE",
"OXYCODONE",
"NALOXONE",
"CHLORHYDRATE DE NALOXONE DIHYDRATÉ"
],
"authorisationProcedure": "Procédure décentralisée",
"prescriptionConditions": [
"prescription limitée à 4 semaines",
"prescription en toutes lettres sur ordonnance sécurisée",
"stupéfiants"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930241639"